ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM
SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company, announces it has entered into a Definitive Manufacturing Agreement with CGM Medical Technology Shen Zhen...
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations
SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus platinum-based...
ShawKwei & Partners Completes Acquisition and Delisting of PEC Ltd
SINGAPORE, June 19, 2025 /PRNewswire/ -- ShawKwei & Partners ("ShawKwei"), an Asian private equity industrial investor, has completed the US$165 million acquisition and final delisting of PEC Ltd ("PEC") from the Singapore Exchange. The PEC...
United Risk Completes Acquisition of Pinnacle Underwriting Based in Sydney, Australia Expanding and Strengthening Operations in the Asia-Pacific and Middle East Regions in Key Lines of Business
Specialty facultative reinsurance MGA bolsters United Risk's business, among the largest in the world and now unique for its diversified scale and geographic reach NEW YORK, June 18, 2025 /PRNewswire/ -- Mr. Hayden Smith, United Risk's Regional CEO...
Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC
SHANGHAI, June 16, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4...
Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels
CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate the...
Kashgar Completes Xinjiang's First 10-GW Photovoltaic Base
Construction of Southern Xinjiang's New Power System Demonstration Zone Enters New Phase KASHGAR, China, June 11, 2025 /PRNewswire/ -- On May 30, with the full-capacity grid connection of projects like the Huadian Kashgar Jiashi 300 MW Ecological...
Cango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin Focus
SHANGHAI, May 29, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a rapidly expanding leader in Bitcoin mining, has finalized the divestment of all its business in the PRC (the "PRC Business"), a strategic transaction valued...
Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia
HANGZHOU, China, March 10, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its...
Hankook & Company Group Completes Acquisition of Hanon Systems
"Tires, Batteries, Thermal Management": Completing Three Core Portfolios to Become a Global High-Tech Leading Group 10 Years of Investment Culminates in Stable Integration, Synergy Creation, and Financial Structure Improvement Soo Il Lee Appointed...